The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity

Table 1

Patient characteristics and significance of ICOSL expression in clinical parameters.

Characteristic	High expression (n = 136)	Low expression (n = 89)	value
Sex			0.888
Male	91	68
Female	45	31
Age			0.475
≥50	86	61
<50	50	28
BMI (kg/m^2)			0.879
≥23	52	27
<23	84	41
WHO histologic type			0.201
Differentiated	44	37
Undifferentiated	92	52
EBV infection			0.266
Positive	80	59
Negative	56	30
T classification			0.024
T1 + T2	94	48
T3 + T4	42	41
Lymph node metastasis			0.020
Absent	82	39
Present	54	50
Distant metastasis			0.038
Absent	130	78
Present	6	11
Overall stage
I + II	93	40
III + IV	43	49

BMI: body mass index; EBV: Epstein–Barr virus.